Studies from Duke University Update Current Data on Melanoma (Breaking Ngf-trka Immunosuppression In Melanoma Sensitizes Immunotherapy for Durable Memory T Cell Protection)

MLA

“Studies from Duke University Update Current Data on Melanoma (Breaking Ngf-Trka Immunosuppression In Melanoma Sensitizes Immunotherapy for Durable Memory T Cell Protection).” Immunotherapy Weekly, 14 Feb. 2024, p. 38. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.782047193&authtype=sso&custid=ns315887.

APA

Studies from Duke University Update Current Data on Melanoma (Breaking Ngf-trka Immunosuppression In Melanoma Sensitizes Immunotherapy for Durable Memory T Cell Protection). (2024, February 14). Immunotherapy Weekly, 38.

Chicago

Immunotherapy Weekly. 2024. “Studies from Duke University Update Current Data on Melanoma (Breaking Ngf-Trka Immunosuppression In Melanoma Sensitizes Immunotherapy for Durable Memory T Cell Protection),” February 14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.782047193&authtype=sso&custid=ns315887.